Close Menu

NEW YORK (GenomeWeb) – LGC said today that it has acquired BioAutomation, which manufactures the MerMade line of oligonucleotide synthesis instruments.

Terms of the deal were not disclosed.

BioAutomatic was founded in 1999 and employs 17 people at its facility in Irving, Texas. Its MerMade products include eight instruments that can synthesize four to 192 oligos simultaneously at scale ranges from 50 nmol to 200 umol, according to LGC. It also distributes consumables used during the synthesis process.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.